Cim Investment Management Inc Acadia Pharmaceuticals Inc Transaction History
Cim Investment Management Inc
- $333 Million
- Q1 2024
A detailed history of Cim Investment Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cim Investment Management Inc holds 18,670 shares of ACAD stock, worth $357,343. This represents 0.1% of its overall portfolio holdings.
Number of Shares
18,670
Previous 10,252
82.11%
Holding current value
$357,343
Previous $320,000
7.81%
% of portfolio
0.1%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding ACAD
# of Institutions
303Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$820 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$265 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$255 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$223 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$115 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.1B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...